Ilsung Pharm (003120) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.002x

Based on the latest financial reports, Ilsung Pharm (003120) has a cash flow conversion efficiency ratio of -0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-731.20 Million ≈ $-495.52K USD) by net assets (₩378.93 Billion ≈ $256.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Ilsung Pharm worth for the company's overall valuation and market capitalisation.

Ilsung Pharm - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Ilsung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ilsung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ilsung Pharm ranked by their cash flow conversion efficiency. Explore Ilsung Pharm (003120) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Taseco Air Services JSC VN:AST	0.091x
Orbitech Co. Ltd KQ:046120	-0.069x
Bcl Industries Limited NSE:BCLIND	0.110x
Nicola Mining Inc V:NIM	0.542x
Biosolution Co.Ltd KQ:086820	0.001x
Faraday Future Intelligent Electric Inc NASDAQ:FFIE	-0.389x
Daishin Information & Communications Co.Ltd KQ:020180	-0.060x
Stillwater Critical Minerals Corp V:PGE	-0.113x

Annual Cash Flow Conversion Efficiency for Ilsung Pharm (2013–2025)

The table below shows the annual cash flow conversion efficiency of Ilsung Pharm from 2013 to 2025. View today's stock price for Ilsung Pharm for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩386.34 Billion ≈ $261.82 Million	₩3.88 Billion ≈ $2.63 Million	0.010x	+190.91%
2024-12-31	₩385.13 Billion ≈ $261.00 Million	₩-4.26 Billion ≈ $-2.88 Million	-0.011x	+89.80%
2023-12-31	₩382.75 Billion ≈ $259.39 Million	₩-41.47 Billion ≈ $-28.11 Million	-0.108x	-23.91%
2022-12-31	₩445.57 Billion ≈ $301.95 Million	₩-38.97 Billion ≈ $-26.41 Million	-0.087x	-630.33%
2021-12-31	₩345.91 Billion ≈ $234.42 Million	₩5.70 Billion ≈ $3.87 Million	0.016x	+267.94%
2020-12-31	₩347.48 Billion ≈ $235.48 Million	₩1.56 Billion ≈ $1.06 Million	0.004x	-64.72%
2019-12-31	₩345.49 Billion ≈ $234.13 Million	₩4.39 Billion ≈ $2.97 Million	0.013x	-72.70%
2018-12-31	₩324.34 Billion ≈ $219.80 Million	₩15.09 Billion ≈ $10.23 Million	0.047x	+47.86%
2017-12-31	₩322.83 Billion ≈ $218.77 Million	₩10.16 Billion ≈ $6.88 Million	0.031x	+132.48%
2016-12-31	₩320.10 Billion ≈ $216.93 Million	₩-31.01 Billion ≈ $-21.02 Million	-0.097x	-610.55%
2015-12-31	₩318.34 Billion ≈ $215.74 Million	₩6.04 Billion ≈ $4.09 Million	0.019x	+48.84%
2014-12-31	₩328.68 Billion ≈ $222.74 Million	₩4.19 Billion ≈ $2.84 Million	0.013x	-18.74%
2013-12-31	₩322.74 Billion ≈ $218.72 Million	₩5.06 Billion ≈ $3.43 Million	0.016x	--

About Ilsung Pharm

KO:003120 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$105.81 Million

₩156.13 Billion KRW

Market Cap Rank

#19084 Global

#923 in Korea

Share Price

₩21800.00

Change (1 day)

-1.13%

52-Week Range

₩18300.00 - ₩28300.00

All Time High

₩31693.76